Peter J. Kuipers's most recent trade in Clover Health Investments Corp - Ordinary Shares - Class A was a trade of 217,382 Class A Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on July 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Clover Health Investments Corp | Peter J. Kuipers | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.89 per share. | 29 Jul 2025 | 217,382 | 6,132,591 | - | 2.9 | 628,234 | Class A Common Stock |
| Clover Health Investments Corp | Peter J. Kuipers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 326,647 | 6,349,973 | - | 0 | Class A Common Stock | |
| Clover Health Investments Corp | Peter J. Kuipers | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.45 per share. | 29 Apr 2025 | 825,989 | 6,023,326 | - | 3.4 | 2,849,662 | Class A Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | EVP, EXECUTIVE ADVISOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.32 per share. | 15 Jun 2023 | 2,292 | 54,900 (0%) | 0% | 72.3 | 165,757 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | EXECUTIVE V P& CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.44 per share. | 15 Dec 2022 | 4,196 | 57,130 (0%) | 0% | 48.4 | 203,254 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | EXECUTIVE V P& CFO | Sale of securities on an exchange or to another person at price $ 108.29 per share. | 26 Aug 2022 | 15,481 | 61,326 (0%) | 0% | 108.3 | 1,676,458 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | EXECUTIVE V P& CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.91 per share. | 26 Aug 2022 | 11,460 | 76,826 (0%) | 0% | 78.9 | 904,309 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | EXECUTIVE V P& CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2022 | 11,460 | 17,248 | - | - | Stock Option NQ (Right to Buy) | |
| Omnicell, Inc. | Peter J. Kuipers | EXECUTIVE V P& CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2022 | 4,040 | 0 | - | - | Stock Option NQ (Right to Buy) | |
| Omnicell, Inc. | Peter J. Kuipers | EXECUTIVE V P& CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.25 per share. | 26 Aug 2022 | 4,040 | 65,366 (0%) | 0% | 44.3 | 178,770 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | EXECUTIVE V P& CFO | Sale of securities on an exchange or to another person at price $ 108.74 per share. | 26 Aug 2022 | 19 | 76,807 (0%) | 0% | 108.7 | 2,066 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | EXECUTIVE V P& CFO | Sale of securities on an exchange or to another person at price $ 105.93 per share. | 22 Aug 2022 | 11,000 | 61,326 (0%) | 0% | 105.9 | 1,165,229 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | EXECUTIVE V P& CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2022 | 11,000 | 4,040 | - | - | Stock Option NQ (Right to Buy) | |
| Omnicell, Inc. | Peter J. Kuipers | EXECUTIVE V P& CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.25 per share. | 22 Aug 2022 | 11,000 | 72,326 (0%) | 0% | 44.3 | 486,750 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | EXECUTIVE V P& CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.11 per share. | 15 Jun 2022 | 4,193 | 61,326 (0%) | 0% | 113.1 | 474,270 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 19,040 | 67,199 (0%) | 0% | 0 | Common Stock | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.21 per share. | 14 Mar 2022 | 1,680 | 65,519 (0%) | 0% | 131.2 | 220,433 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 9,988 | 57,679 (0%) | 0% | 0 | Common Stock | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Dec 2021 | 3,740 | 47,335 (0%) | 0% | 0 | Common Stock | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 5,640 | 59,592 (0%) | 0% | 0 | Common Stock | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 5,640 | 0 | - | - | Stock Option NQ (Right to Buy) | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 181.45 per share. | 08 Dec 2021 | 4,649 | 53,952 (0%) | 0% | 181.4 | 843,561 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 181.00 per share. | 08 Dec 2021 | 2,353 | 51,107 (0%) | 0% | 181 | 425,893 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 180.43 per share. | 08 Dec 2021 | 991 | 58,601 (0%) | 0% | 180.4 | 178,806 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 180.41 per share. | 08 Dec 2021 | 492 | 53,460 (0%) | 0% | 180.4 | 88,762 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 182.44 per share. | 08 Dec 2021 | 32 | 51,075 (0%) | 0% | 182.4 | 5,838 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 15,587 | 81,909 (0%) | 0% | 0 | Common Stock | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 146.24 per share. | 02 Aug 2021 | 11,699 | 66,322 (0%) | 0% | 146.2 | 1,710,895 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 10,887 | 0 | - | - | Stock Option NQ (Right to Buy) | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 146.23 per share. | 02 Aug 2021 | 4,910 | 59,812 (0%) | 0% | 146.2 | 717,989 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 4,700 | 0 | - | - | Stock Option NQ (Right to Buy) | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 145.73 per share. | 02 Aug 2021 | 3,888 | 78,021 (0%) | 0% | 145.7 | 566,593 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 145.71 per share. | 02 Aug 2021 | 1,600 | 64,722 (0%) | 0% | 145.7 | 233,142 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Jun 2021 | 3,132 | 66,322 (0%) | 0% | 0 | Common Stock | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 135.76 per share. | 18 May 2021 | 1,231 | 69,911 (0%) | 0% | 135.8 | 167,121 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 134.49 per share. | 18 May 2021 | 707 | 71,142 (0%) | 0% | 134.5 | 95,084 | Common Stock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Sale of securities on an exchange or to another person at price $ 136.53 per share. | 18 May 2021 | 457 | 69,454 (0%) | 0% | 136.5 | 62,394 | Common Ttock |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Mar 2021 | 575 | 71,849 (0%) | 0% | 0 | Common Stock | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 11,350 | 71,713 (0%) | 0% | 0 | Common Stock | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 9,520 | 60,363 (0%) | 0% | 0 | Common Stock | |
| Omnicell, Inc. | Peter J. Kuipers | Executive V P& CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Dec 2020 | 3,747 | 50,843 (0%) | 0% | 0 | Common Stock |